Risarestat (CT-112) is a dual-action small molecule functioning as a potent aldose reductase inhibitor and a thyroid hormone receptor antagonist. It is utilized in research for investigating diabetic complications and metabolic disorders, with applications in both in vitro enzymatic assays and in vivo models of hyperglycemia and hypoglycemia.
